Malignant biliary obstruction, stent, cost/cost effectiveness, quality of life, prognosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Obstructive malignancy at the level of the extrahepatic CBD 2. Inoperability due to a poor medical condition, local irresectability or distant metastases 3. Serum bilirubin >50 micromol/L 4. Informed consent.
Exclusion criteria
Exclusion criteria: 1. Malignancy involving intrahepatic bile ducts and duodenum 2. Known history of cholecystitis (unless cholecystectomy has been performed) 3. WHO performance score of 4 (100% of ime in bed) 4. Unable to fill out quality of life questionnaires 5. Known history of operation of the bile ducts (unless cholecystectomy has been perfromed).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Medical effects | — |
Secondary
| Measure | Time frame |
|---|---|
| - Quality of life - Cost/Cost effectiveness | — |
Contacts
Universitair Medisch Centrum Utrecht Postbus 85500 3508 GA Utrecht